Claborn Kasey R, Aston Elizabeth R, Champion Jane, Guthrie Kate M
J Assoc Nurses AIDS Care. 2018 Sep-Oct;29(5):642-654. doi: 10.1016/j.jana.2018.05.010. Epub 2018 Jun 5.
HIV treatment retention remains a significant public health concern. Our qualitative analysis used emergent data from a larger HIV treatment study to explore clinician perspectives on prescribing opioids to incentivize retention in HIV care. Data from individual interviews with 29 HIV and substance use clinicians were analyzed using thematic analysis. Prescribing opioids as a retention strategy emerged as a theme. Nine of 11 HIV clinicians reported prior knowledge of this practice; only one of 12 substance use clinicians indicated prior knowledge. Positive perceptions included: harm reduction approach, increased appointment attendance, and sustained engagement in HIV care. Negative perceptions included: addiction potential, increased engagement not leading to better health outcomes, and prescriptions becoming the appointment focus. Some clinicians used prescriptions as a strategy to improve treatment retention, which may be particularly problematic in light of the current opioid epidemic. Understanding motives, outcomes, and clinical decision-making processes is needed.
艾滋病毒治疗的持续性仍然是一个重大的公共卫生问题。我们的定性分析利用了一项更大规模的艾滋病毒治疗研究中的新出现数据,以探讨临床医生对于开具阿片类药物以激励患者持续接受艾滋病毒治疗的看法。对29名艾滋病毒和药物使用方面的临床医生进行的个人访谈数据采用主题分析法进行了分析。将开具阿片类药物作为一种持续性策略成为了一个主题。11名艾滋病毒临床医生中有9名报告称了解这种做法;12名药物使用临床医生中只有1名表示了解。积极看法包括:减少伤害方法、增加就诊率以及持续参与艾滋病毒治疗。消极看法包括:成瘾可能性、参与度增加但未带来更好的健康结果以及处方成为就诊重点。一些临床医生将开具处方作为提高治疗持续性的一种策略,鉴于当前的阿片类药物流行情况,这可能会带来特别严重的问题。需要了解其中的动机、结果和临床决策过程。